Daiichi Sankyo Archives - Onco'Zine

Home Tags Daiichi Sankyo

Lung Cancer Research Foundation Signs Collaboration Agreement with Daiichi Sankyo and...

Editorial Team - March 21, 2023

Novel ADC Doubles Progression-Free Survival in Metastatic Breast Cancer with Low...

Danielle Garcia - June 6, 2022

A doctor examines mammogram snapshot of breast of patient on the monitors.

Trastuzumab deruxtecan Launched in Japan for HER2+ Unresectable or Metastatic Breast...

Editorial Team - May 25, 2020

Featured Image: Daiichi Sankyo Booth at the annual meeting of the American Association for Cancer Research (AACR) 2018 Courtesy: © 2017 – 2018. Sunvalley Communication, LLC / Evan Wendt. Used with permission.

Daiichi Sankyo Submits sNDA to Japan’s Regulator for Trastuzumab Deruxtecan in...

Danielle Garcia - May 7, 2020

Ian E Krop, MD, Ph.D, Associate chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, speaks during the General Session on Wednesday, December 11, 2019. during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. Photo coutesy © 2019 AACR/SABCS Todd Buchanan.

SABCS 2019: Trastuzumab Deruxtecan Achieves Clinically Meaningful and Durable Response

Peter Hofland - December 13, 2019

Investigational ADC is Well Tolerated with Partial Dose-dependent Response in NSCLC

Peter Hofland - September 11, 2019

Featured Image: Daiichi Sankyo Booth at the annual meeting of the American Association for Cancer Research (AACR) 2018 Courtesy: © 2017 – 2018. Sunvalley Communication, LLC / Evan Wendt. Used with permission.

WCLC 2019: Daiichi Sankyo to Present Results from First-in-class HER3...

Peter Hofland - August 27, 2019

Daiichi Sankyo Initiates Phase I Study to Evaluate the Combination Quizartinib...

Peter Hofland - December 20, 2018

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

Peter Hofland - December 19, 2018

European Medicines Agency Validates and Grants Accelerated Assessment for Quizartinib in...

Danielle Garcia - November 5, 2018

12 Page 1 of 2

LATEST NEWS

Drug Combination Shows Promise in Treatment of Nerve Sheath Tumors

Editorial Team - December 1, 2023

Genomic Nasal Swab Test may Improve Lung Cancer Risk Assessment for Smokers with Lung...

Editorial Team - November 30, 2023

Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery

Peter Hofland - November 25, 2023

Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?

Editorial Team - November 24, 2023

Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments

Brandon H. McNaughton, Ph.D. - November 23, 2023

Press Releases | Cancer

ITAAN Pharma and ACIC Pharmaceuticals Form Strategic Joint Venture Partnership December 5, 2023
ITAAN Pharma and ACIC Pharmaceuticals join forces in a strategic venture to advance generic injectables for the North American market. The collaboration is for enhanced product development and manufacturing excellence, resulting in a comprehensive range of critical injectable products....
Unitek Learning Wins Award of Excellence in Faculty Development December 5, 2023
Unitek sets new standards for faculty development in online education NEWPORT BEACH, Calif., Dec. 5, 2023 /PRNewswire-PRWeb/ -- Unitek Learning has been selected by the Online Learning Consortium (OLC) as the winner of the Award of Excellence in Faculty Development for their project...
Dimensional Insight Rated as #1 Solution for Outsourced Healthcare Data Analytics by Black Book Research December 5, 2023
With outsourcing on the rise, healthcare customers ranked Dimensional Insight as the top outsourced analytics solution BURLINGTON, Mass., Dec. 5, 2023 /PRNewswire-PRWeb/ -- Dimensional Insight®, an award-winning enterprise data management and analytics provider, has been recognized as the...